Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors. including RET (Rearrange during transfection). vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR). The activity against RET and VEGF made it a good choice in the treatment of medullary thyroid cancer (MTC). https://www.roneverhart.com/Tokidoki-X-Hello-Kitty-and-Friends-1-Blind-Box/